Investing experts: Why 'just buy the market' doesn't necessarily apply to bonds

The tradeable message is not “buy bonds,” it is “buy the right part of the curve.” Core-aggregate exposure is effectively a moderate-duration bet with a credit-quality overlay; when the market is still pricing additional tightening, that package has worse convexity than many investors assume. Over the next 1-3 months, the cleaner expression is short-duration cash substitutes over broad bond beta, because the carry gap can be overwhelmed by a small move up in front-end yields.

Second-order losers are the duration-sensitive wrappers that retail uses as “safe” assets: AGG-like funds, intermediate Treasuries, and anything benchmarked to the belly of the curve. That pressure can spill into rate-sensitive equity groups with debt-funded balance sheets, since a higher discount rate raises both funding costs and equity-duration compression. The key falsifier is a fast rollover in inflation or a clear dovish shift from the Fed; that would reprice duration sharply higher and punish any short-bond stance.

The contrarian point is that consensus is too dismissive of recession hedging value. If growth cracks before the hiking cycle is fully delivered, the same Treasurys that look like low-yield ballast become the best-performing part of a balanced portfolio, and credit should lag the aggregate. So this is not a blanket bearish call on fixed income; it is a timing call on duration versus carry, with the next CPI/Fed sequence likely to decide the trade.